Hunseem AG

Hunseem AG is a new small-molecule targeted drug developer based in Switzerland, primarily focusing on innovative treatments for suppressing tumors in specific tissues and central nervous system diseases. Hunseem AG inhibits tumor cell growth and cancer metastasis by cleaving collagen, offering products such as small-molecule drugs and small-molecule inhibitors.